Catherine C Turkel - President, Novus Therapeutics, Inc

As of March 20, 2020


Catherine C Turkel Net Worth

  • Net worth is estimated to be at least $191.64K
  • Owns at least 88,662 units of Novus Therapeutics, Inc stock
  • Sold an estimated value of $18.61K in the last 3 years at Novus Therapeutics, Inc

Catherine C Turkel Trading

  • Largest purchase of shares was 33,680 units , worth over $161.15K on September 13, 2018
  • Largest sale of shares was 9,537 units , worth over $18.61K on May 22, 2019
  • In total has made about 10 transactions over 3 years
  • Usually trades in September, May and March, with the busiest year in 2018, 2017 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Catherine C Turkel Mailing Address

  • Mailing address is 19900 MacArthur Blvd., Suite 550 Irvine CA 92612 CA

Novus Therapeutics, Inc Insider Trading

  • The most recent transaction was 103,200 units sold on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed worth over $2.23M
  • In the last 3 years, insiders at Novus Therapeutics, Inc sold an estimated value of $2.63M and bought an estimated value of $7.31M
  • The most active traders are Catherine C Turkel, President,  Gregory J Flesher, Chief Executive Officer,  and Jon Kuwahara, See Remarks
  • Insider trading is most common in May, with the busiest year in 2019

Eledon Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1